Antiviral drug discovery plays a critical role in global public health by combating viral infections that pose significant morbidity and mortality worldwide. Despite notable successes in treating diseases such as HIV, hepatitis B and C, and influenza, the discovery and development of effective antiviral agents remain highly challenging. Rapid viral mutation, emerging and re-emerging viral pathogens, limited therapeutic targets, and safety concerns complicate the process.